Patent ID: 8754032
Filing Date: 2014-06-17
Classification: A61K,A61P

Abstract:
1. A method for treating hyperglycemia, diabetes, an insulin resistant glucose metabolism disorder, an impaired glucose tolerance condition, or an impaired fasting plasma glucose condition in a warm-blooded mammal, which comprises simultaneously or separately administering (a) 1-50 mg of 3-{(2S,4S)-4-[4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl]pyrrolidin-2-ylcarbonyl}thiazolidine 2.5 hydrobromide, or a hydrate thereof, and (b) an antidiabetic drug selected from the group consisting of (i) a sulfonylurea agent, (ii) a glitazone, (iii) a biguanide, and (iv) an alpha-glucosidase inhibitor, or a pharmaceutically acceptable salt thereof, to a warm-blooded mammal, thereby treating hyperglycemia, diabetes, an insulin resistant glucose metabolism disorder, an impaired glucose tolerance condition, or an impaired fasting plasma glucose condition in the warm-blooded mammal.